Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M O'Cathail

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|February 19, 2017
Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell CarcinomasSamantha J Cox, Sean M O'Cathail, Bernadette Coles, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal CancerCatherine R Hanna, Séan M O'Cathail, Janet Graham, et al.
Future Oncology (London, England)|December 26, 2013
Activity of eribulin mesylate in heavily pretreated breast cancer granted access via the Cancer Drugs FundRamya Ramaswami, Sean M O'Cathail, James H Brindley, et al.
Cancer Genetics|September 2, 2020
NRF2 metagene signature is a novel prognostic biomarker in colorectal cancerSéan M O'Cathail, Chieh-Hsi Wu, Annabelle Lewis, et al.
Antioxidants (Basel, Switzerland)|September 28, 2021
NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic SwitchSéan M O'Cathail, Chieh-Hsi Wu, Rachael Thomas, et al.
Advances in Radiation Oncology|December 11, 2020
Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and ToxicityThomas Smith, Sean M O'Cathail, Sabrina Silverman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 21, 2025
Review of Radiotherapy Activity in Scotland, 2 Years Post COVIDL Grocutt, T Rowe, D Caldwell, et al.
Clinical and Translational Radiation Oncology|September 18, 2023
Patient-reported outcomes in PROSPECT trial (Alliance N1048) - FOLFOX is not a panaceaSean M O'Cathail, Richard Adams, Maria A Hawkins, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 10, 2025
Neoadjuvant Treatment of Rectal Cancer: A Repeat UK-wide Survey After Implementation of National Intensity Modulated Radiotherapy GuidanceA Macnair, R Adams, A Appelt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 17, 2022
The Impact of COVID-19 on Radiotherapy Services in Scotland, UK: A Population-based StudyL Grocutt, A Rutherford, D Caldwell, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|February 19, 2017
Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell CarcinomasSamantha J Cox, Sean M O'Cathail, Bernadette Coles, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal CancerCatherine R Hanna, Séan M O'Cathail, Janet Graham, et al.
Future Oncology (London, England)|December 26, 2013
Activity of eribulin mesylate in heavily pretreated breast cancer granted access via the Cancer Drugs FundRamya Ramaswami, Sean M O'Cathail, James H Brindley, et al.
Cancer Genetics|September 2, 2020
NRF2 metagene signature is a novel prognostic biomarker in colorectal cancerSéan M O'Cathail, Chieh-Hsi Wu, Annabelle Lewis, et al.
Antioxidants (Basel, Switzerland)|September 28, 2021
NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic SwitchSéan M O'Cathail, Chieh-Hsi Wu, Rachael Thomas, et al.
Advances in Radiation Oncology|December 11, 2020
Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and ToxicityThomas Smith, Sean M O'Cathail, Sabrina Silverman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 21, 2025
Review of Radiotherapy Activity in Scotland, 2 Years Post COVIDL Grocutt, T Rowe, D Caldwell, et al.
Clinical and Translational Radiation Oncology|September 18, 2023
Patient-reported outcomes in PROSPECT trial (Alliance N1048) - FOLFOX is not a panaceaSean M O'Cathail, Richard Adams, Maria A Hawkins, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 10, 2025
Neoadjuvant Treatment of Rectal Cancer: A Repeat UK-wide Survey After Implementation of National Intensity Modulated Radiotherapy GuidanceA Macnair, R Adams, A Appelt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 17, 2022
The Impact of COVID-19 on Radiotherapy Services in Scotland, UK: A Population-based StudyL Grocutt, A Rutherford, D Caldwell, et al.
Pageof 5